Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Solid Tumor 2 Neoplasms 2 Meningioma 2 Breast Neoplasms 2 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Neurofibromatosis 2 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Fallopian Tube Neoplasms 1 Estrogen Receptor Positive Breast Cancer 1 Endometrial Neoplasms 1 Disease 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Advanced Cancer 1 Adenocarcinoma 1

Interventions

Blood Specimen Collection 9 Surveys and Questionnaires 5 Magnetic Resonance Spectroscopy 5 Biopsy 5 Prednisone 4 Colonoscopy 4 Biopsy, Fine-Needle 4 Tomography, X-Ray Computed 3 Surgical Procedures, Operative 3 Mammography 3 Magnetic Resonance Imaging 3 Liquid Biopsy 3 Lenalidomide 3 Interviews as Topic 3 Exercise 3 Diagnostic Tests, Routine 3 Cyclophosphamide 3 weifuchun 2 pembrolizumab 2 obinutuzumab 2 Urination 2 Preoperative Exercise 2 Positron Emission Tomography Computed Tomography 2 Observation 2 Methods 2 Melphalan 2 Immunohistochemistry 2 Hematologic Tests 2 Gemcitabine 2 Educational Status 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Disease × vistusertib × Clear all

NCT02064608 2019-07-17

CaNCaP02

Cambridge University Hospitals NHS Foundation Trust

Phase 1 Completed

Disease, Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡